Podcasts about truveta

Send us a textIn this episode of the HealthBiz Podcast, host David Williams sits down with Terry Myerson, CEO and co-founder of Truveta, to explore how aggregated electronic medical record (EMR) data can drive groundbreaking insights in clinical research, drug development, and healthcare innovation. Terry shares his journey from mechanical engineering to tech entrepreneurship, his years at Microsoft, and how Truveta is using data to improve patient outcomes and save lives.

“There’s no digital feedback loop in health care, you have it in Tesla, in Netflix, in Amazon — but not in the industry that impacts every life,” Terry Myerson, CEO of Truveta, explains to Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. Myerson joins BI analyst Jonathan Palmer to discuss Truveta’s mission to aggregate and analyze health data across 30 major US health systems, covering one-third of Americans. He details the company’s work in regulatory-grade safety and efficacy research, the launch of the Truveta Genome Project with partners like Regeneron and Illumina, and the power of AI-driven insights to accelerate medical discovery. The conversation explores Truveta’s efforts to address data fragmentation, privacy, and interoperability challenges that must be solved to revolutionize patient care and life sciences.See omnystudio.com/listener for privacy information.

In this podcast episode, Jay Nanduri, CTO and Co-founder of Truveta, shares his journey from spending over 20 years at Microsoft to founding a healthcare data company. Jay discusses the personal reasons behind his shift to healthcare, motivated by his family's struggles with cancer and the difficulties of transferring medical records. He also touches on the challenges of leaving a well-established company like Microsoft, the differences in working in a startup versus a large corporation, and the importance of purpose, trust, risk management, and financial planning in building a new company. Jay's story highlights the value of leveraging one's network, reputation, and experience in entrepreneurial ventures. Highlights: 00:10 The Genesis of Truveta: From Microsoft to Healthcare Innovation 03:22 Personal Motivations: A Family's Health Crisis Sparks a Vision 05:32 The Leap of Faith: Transitioning from Microsoft to Startup Life 10:42 The Startup Journey: Challenges, Insights, and the Drive for Purpose 20:47 Reflections and Advice: Navigating the Startup Ecosystem ---- Thank you so much for checking out this episode of The Tech Trek. We would appreciate it if you would take a minute to rate and review us on your favorite podcast player. Want to learn more about us? Head over at https://www.elevano.com Have questions or want to cover specific topics with our future guests?Please message me at https://www.linkedin.com/in/amirbormand (Amir Bormand)

In this compelling episode of The Medical Sales Podcats, join Samuel Adeyinka and his special guest, Adam Mostafa, a titan in the field of healthcare sales and Managing Director of Business Development at TruVeta, as he delves into the data revolution transforming the medical device industry. With over a decade of rich experience that stretches from pharmaceuticals to medical devices and now healthcare data analytics, Adam provides unparalleled insights into the power of real-world evidence in driving sales strategies and regulatory success. Learn how Adam's innovative mindset and strategic prowess played a pivotal role in launching the V-Lock suture, propelling it to become the benchmark in robotic surgery. Discover how TruVeta is shaping the future of healthcare by harnessing EHR-related data to fuel research and development for medical device companies and pharmaceuticals alike. Adam's journey from a pharmaceutical representative to a driving force behind healthcare technology underscores the critical importance of embracing change and the ever-growing reliance on data in the healthcare sector. Whether you're a seasoned professional in healthcare sales or simply intrigued by the integration of data and medical advancements, this episode is an essential listen. Equip yourself with the knowledge and strategies needed to excel in the fast-paced, data- driven world of healthcare sales with insights from an industry leader who's not only witnessed but also shaped its evolution. Ps: Adam's best book read. Manifest: 7 Steps to Living Your Best Life, Book by Roxie Nafous.   Additional note from the guest! "I want to make sure I point out though that when I'm talking about the prostatectomy I mentioned taking out the bladder neck and urethra. That doesn't happen you join the bladder neck and urethra together because you are taking out the prostate creating an anasramosis of the two structures.”

Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. Today we have some exciting news to share with you. Eli Lilly has recently entered into a collaboration with Tokyo-based Prism Biolab to develop small molecule inhibitors of protein-protein interactions. This partnership aims to target protein-protein interactions, which play a critical role in various disease processes. By developing drugs that can disrupt these interactions, there is potential for novel therapies for diseases such as cancer and autoimmune disorders. Lilly will be paying up to $660 million to gain access to Prism Biolab's proprietary platform.In another partnership, Boehringer Ingelheim has teamed up with Phenomic AI to develop targets for stroma-rich cancers. Stroma-rich cancers are known for their resistance to treatment, so by targeting the stroma, there is hope that the efficacy of cancer therapies can be enhanced. Boehringer Ingelheim will be paying $9 million upfront, with the potential for up to $500 million in milestone payments.Moving on to some interesting research, real-world data suggests that Eli Lilly's tirzepatide may achieve stronger and faster weight loss compared to Novo Nordisk's semaglutide in patients with type 2 diabetes. Healthcare analytics firm Truveta analyzed electronic health records and found promising results for tirzepatide.In regulatory news, the FDA has launched an investigation into malignancies linked to CAR-T therapies. The agency is evaluating the risk of T cell malignancies associated with CAR-T treatment and may take regulatory action if necessary.Shifting gears, we have some updates from the business world. Verve Therapeutics' stock price has recently dropped following a $148 million public offering. On a positive note, Novartis has raised its growth target as part of its "pure-play" strategy and has made adjustments to its pipeline.On a more global scale, a recent comparison of drug prices in the U.S. and other countries reveals significant variations, highlighting the complexities of pricing in the pharmaceutical industry.In our podcast section, we will be discussing recent deals in the industry, drug shortages for Dupixent and GLP-1 drugs, and the challenges faced by contract development and manufacturing organizations in 2023.Thank you for tuning in to Pharma and Biotech Daily. Stay informed, stay curious, and have a great day!

Each day, valuable patient data collected by healthcare systems. When used properly as part of healthcare analytics, this can help drive better outcomes for both patients and providers. However, when data management is not effectively implemented, organizations lose out on these benefits. Terry Myerson, CEO of Truveta, saw the need to unlock data's potential while still ensuring privacy and security. In this episode, he discusses his company's unique approach,  the urgent need for better data insights for treatment protocols, and how AI is creating both efficiencies and concerns when making sense of data.Tune in to learn:The origin of Truveta [6:28]Pulling data from the provider, not the patient [9:47]Fragmentation, privacy, and unstructured data [11:58]Healthcare data trends [15:50]Population-level data [17:49]Bringing in data from multiple systems [23:08]Why transparency earns trust [26:10]Language models and generative AI [28:10]Terry's career journey [35:29]Mentions: Providence HealthcareCNNRogaineOzempicBoston ScientificNational Library of MedicineBloombergMicrosoftWorld Health OrganizationCommon SpiritTrinity HealthThe Emperor of All MaladiesMacklemoreGet even more insights from data and analytics leaders like Terry on The Data Chief.  Mission.org is a media studio producing content for world-class clients. Learn more at mission.org.

In this episode, I interview speech and language pathologist, Lenora Edwards, M.S. CCC-SLP, to address the concerns that many of you have regarding your child's delayed speech and communication skills. Here are some interesting facts about speech delays in children. In an analysis of nearly 2.5 million children younger than 5 years old, researchers at health-analytics company, Truveta, found that for each year of age, first-time speech delay diagnosis increased by an average of 1.6 times between 2018-19 and 2021-22. The highest increase was among 1-year-olds, the researchers said. But why are we seeing this trend? Is it due to the pandemic? Is it due to the increase of screen time as a society? Our special guest helps us have this important conversation as well as provide insights if you suspect your child needs help.About This Episode's Special Guest:Website: https://www.betterspeech.com/Start Now: https://www.betterspeech.com/start-nowBetter Speech Resources: https://www.betterspeech.com/blogFacebook: https://www.facebook.com/yourbetterspeech/TikTok: https://www.tiktok.com/@better.speechInstagram: https://www.instagram.com/betterspeech/Linked In: https://www.linkedin.com/company/better-speech/mycompany/YouTube: https://www.youtube.com/c/BetterSpeechVideoFinancial Assistance: www.betterspeech.com/consult-financial-aid*EMAIL LIST*Click here to join my email list for more free content to help you on your parenting journey!or go to strongermindsstrongeryouth.com/jointhelist*REACH OUT & SHARE*Email me your stories to share with others parents just like you @ jessika@strongermindsstrongeryouth.com *CONNECT WITH ME ON SOCIAL MEDIA!!!* & *TAG ME IN YOUR STORIES!!!*#jessikashields or @strongermindsstrongeryouthGet Social to Stay Connected!!!FB: @StrongerMindsStrongerYouthInstagram: @StrongerMindsStrongerYouthLinkedIn: http://www.linkedin.com/in/jessikashieldsTo access more Podcast resources, visit strongermindsstrongeryouth.comThank you for listening!

For this episode of the eCom Logistics Podcast, we welcome Patrick Nikoletich and Nima Elyassi-Rad, the CTO and the Vice President of Global Business Development of Shippo respectively. We sit with the amazing duo to talk about understanding fulfillment from different perspectives, creating a great delivery experience, and the innovations shaping the space for businesses and consumers alike. ABOUT PATRICK AND NIMAPatrick is a technology executive and founder. He currently serves as the Chief Technology Officer at Shippo managing both product and engineering organizations. Previously, he served as the VP of Product at Truveta focused on developing AI/ML applications to improve the outcomes of patients receiving treatments, at Microsoft in Azure and AI & Research divisions as an engineering and program manager, and working for and leading small businesses developing applications with larger enterprises. In his spare time he enjoys skiing, riding motorcyles and hiking in the Pacific Northwest with his wife and two dogs.Nima, on the other hand, is a technology executive, investor, and founder. He currently serves as the VP of Business Development at Shippo. Previously, he started a soccer brand, spent time as a VC, knows how to sling pizza, and put in time on the 1st and 2s as a Hip Hop radio DJ.HIGHLIGHTS02:25 Logistics from a cost and customer experience perspective09:25 You don't need to have an Amazon-like delivery experience especially early on.15:14 Many copycat brands will start going away.21:13 Innovations and their practical applications in the eCom space today.QUOTES03:53 Any warehouse shipper has to consider someone to be their infrastructure - Nima: "Tech forward folks don't like it, you come for the integration and you stay for the switching cost because it's too expensive to rip something out. But in reality, things are breaking down. So when you are picking a new partner, I think it's important to really vet them to understand are they enterprise-ready and what that readiness means for your organization."23:12 AI and ML applications have been "invading" everyone's lives for many years - Patrick: "The thing that you have to recognize is that 85-90% of ideas around AI and ML applications will probably fail, they won't return any meaningful value and won't be used as something stand-alone that can drive growth and revenue for your business but really the power is in how they augment capabilities."Find out more about amazing guests in the links below:About Patrick: https://www.linkedin.com/in/patrick-nikoletich-99a42918/About Nima: https://www.linkedin.com/in/nima3rad/Website: https://goshippo.com/

Tune in for today's industry updates.

Truveta offers the world's first health data and analytics solution to study patient care and outcomes. In the latest episode of Inspiring Health, CEO Terry Myerson talks about partnering with systems like WellSpan to solve major healthcare challenges and find critical insights to help save patient lives with data. 

Terry Myerson leads a very interesting organization – Truveta – that’s trying to aggregate healthcare data from health systems across the country in a de-identified form. They then combine this data with other sources to generate insights that drive clinical research and outcomes and develop new therapies and molecules. In this episode, Terry discusses Truveta's […]

Terry Myerson leads a very interesting organization – Truveta – that’s trying to aggregate healthcare data from health systems across the country in a de-identified form. They then combine this data with other sources to generate insights that drive clinical research and outcomes and develop new therapies and molecules. In this episode, Terry discusses Truveta's […]

On this episode, Tim Skeen, SVP and CIO of Sentara Healthcare, discusses how he determines his technology priorities and initiatives for driving digital transformation. Norfolk, VA-based is an integrated, not-for-profit healthcare system comprising 12 hospitals. As CIO for Sentara and its affiliated health plan (Optima Health), Tim focuses on driving synergies through technology to improve member/patient experiences, manage population health, and drive efficiencies. Tim explains how data is the foundation to drive better healthcare outcomes and how the right data sets can identify care gaps, lower the cost of care, and improve overall healthcare outcomes. He discusses their strategic partnerships for cloud-enabled data and analytics with Microsoft, including their investments in industry consortium Truveta. He also talks about their cloud transformation journey and the IP they have developed for cloud migration that they intend to monetize through a commercial venture. Take a listen. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

After holding the GeekWire Awards virtually for the past two years, there was a feeling of real catharsis Thursday evening as hundreds of people streamed through the doors of the Showbox Sodo in Seattle for our annual celebration of the Pacific Northwest's top tech startups, leaders, and innovations. For the finalists in the 2022 GeekWire Awards, recognition at the superhero-themed show came with the added bonus of knowing that their companies made it through a period of unprecedented challenge and change. But the week also brought a new sense of uncertainty about what's to come. [Related Post:2022 GeekWire Awards revealed: Community celebrates big winners in Pacific NW tech] Uber CEO Dara Khosrowshahi's widely cited memo on Monday was a flashpoint for the tech industry, adding to existing concerns by warning of a “seismic shift” in the markets, signaling tougher times and tighter belts ahead. Some of the startup CEOs in attendance acknowledged reading his message closely. So we took our cues from the backdrop, literally and figuratively — inviting tech leaders aside at the event to ask questions such as: What's your take on the possibility of new economic realities? What are your biggest challenges and priorities for the rest of the year? And, of course: which superhero best reflects your company's ethos? The result was a glimpse into the collective psyche of the tech community in a key U.S. innovation hub, at a pivotal moment for the country and the world. Guests on this episode, in order of appearance: Xiao Wang, CEO of Boundless Immigration, finalist for CEO of the Year. Maria Karaivanova, co-founder & COO of WhyLabs. Varun Puri, co-founder of Yoodli, winner of Young Entrepreneur of the Year with his co-founder Esha Joshi. Lisa Gurry, COO of Truveta, winner of Health Innovation of the Year Dave Cotter, chief product officer of Leafly, and chair of the Washington Technology Industry Association, sponsor of the Public Policy Champion for Innovation Award. Laura Ruderman, Technology Alliance CEO. David Kirtley, founder and CEO of Helion, finalist for Innovation of the Year. Stephanie Winslow, Teacher, South Kitsap High School, one of three STEM Educators of the Year. Grant Goodale, carrier experience officer, Convoy, past winner of Next Tech Titan. Mo Bhende, co-founder & CEO at Karat, finalist for Next Tech Titan. Faisal Masud, CEO of Fabric, finalist for Next Tech Titan. Kiana Pan, president of CodingDojo, honoree in the Geeks Give Back category. Tushar Garg, CEO of Flyhomes, finalist for Workplace of the Year. Byron Baker, head of design at Blink UX, sponsor and judge in UX Design of the Year. Thanks to the tech leaders who answered our questions, to our GeekWire Awards attendees, finalists, and sponsors, and to our social media partner Jordan Curtis of Line Leader Media for his help with this episode.  Read about all of the GeekWire Awards finalists and winners in our special coverage. Related Episodes: Immigration and tech: New realities, old problems, and what's at stake for the future Key trends in digital commerce, with the former Amazon exec leading Seattle's newest unicorn Ungrading? Letting kids teach IT? GeekWire Award-winning STEM teachers share innovative strategies See omnystudio.com/listener for privacy information.

Truveta announced their new COVID-19 insights and unveiled the Truveta platform for the first time at #ViVE2022. Terry Myerson, Chief Executive Officer joins us for an exclusive interview. Hope you enjoy.

Today's guest is Jay Nanduri, Chief Technical Officer at Truveta in Seattle. Founded in 2020, Truveta's aim is to enable researchers to find cures faster, empower every clinician to be an expert and help families make the most informed decisions about their care. Clinical data from their members is de-identified daily and brought together in an unprecedented data platform to enable research on all health conditions. Truveta believe their collective de-identified data can be used to accelerate research, advance health equity and save lives. Jay is a former Microsoft Technical Fellow with over twenty years of experience, 25+ patents and several publications that demonstrate exemplary technical and business leadership. He has a proven track record of managing and delivering mission critical projects from conception to delivery. Jay also has extensive hands-on experience in designing highly scalable distributed systems, big data, big graph, secure internet platforms, fraud prevention, BI analytics, Ecommerce, personalization, workflow systems and Machine Learning/AI platforms. In the episode, Jay will discuss: His background and previous experience with Microsoft, What motivated him to move to Truveta, The work they do at Truveta and defining their mission statement, Their focus on data coverage, data quality, data consumption and community, Using AI for the benefit of health systems, researchers and clinicians, Using Healthcare Data responsibly and Career opportunities within AI in Healthcare

In this episode, Dr. Ashis Barad, Clinical Lead, Digital Health at Baylor Scott & White Health, discusses their digital patient engagement journey, their highly rated best-in-class homegrown patient mobile app, and how they are creating a seamless digital experience for patients and consumers. BS&W is the largest not-for-profit health system in Texas and is a pioneer in digital patient engagement. Dr. Barad discusses their focus on consumer expectations and consumer research at length and how that drives their digital investments. He discusses the challenges involved in gaining acceptance from clinicians for launching and implementing digital health, and the need to invest in ongoing research to understand consumer needs. Dr. Barad talks about their digital investment priorities for 2022, their data and analytics partnership with the Truveta consortium, challenges with harnessing technology innovation, and how the talent shortage is impacting the pace of digital transformation. Take a listen. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

January 24, 2022: https://www.linkedin.com/in/charlesboicey/ (Charles Boicey) from https://clearsense.com/ (Clearsense) joins Bill for the news today. Truveta and LexisNexis Risk Solutions partner to advance health equity and health research quality. Traditional research rarely has access to social determinants of health or mortality data since 65% of people die outside the hospital. ONC publishes TEFCA details and FHIR roadmap. Trilliant Health discuss the data behind Z codes for social determinants of health. German Bionic releases new wearable AI robotic suits that boost human strength - taking human augmentation to new levels. And Bill and Charles put on their CIO and CTO hats respectively to discuss the clinical and IT labor shortage plus how do we create a platform and mindset of bringing the data and integration points together and setting it up so that the entrepreneurial community can innovate with us? Key Points: 00:00:00 - Intro 00:07:40 - It's been challenging for medical research to include participants representative of the diversity of our country 00:10:10 - Mortality data is notoriously hit and miss 00:15:50 - HIN should collaborate with stakeholders across the continuum of care, to electronically exchange digital health information, even when a stakeholder may be a business competitor https://clearsense.com/ (Clearsense) - https://clearsense.com Stories: https://www.globenewswire.com/news-release/2022/01/18/2368529/0/en/Truveta-and-LexisNexis-Risk-Solutions-Partner-to-Advance-Health-Equity-and-Health-Research-Quality.html (Truveta and LexisNexis Risk Solutions Partner to Advance Health Equity and Health Research Quality) https://www.hcinnovationgroup.com/interoperability-hie/trusted-exchange-framework-and-common-agreement-tefca/article/21253529/onc-publishes-tefca-details-fhir-roadmap?utm_source=HI%20Daily%20NL&utm_medium=email&utm_campaign=CPS220118146&o_eid=3204I9595689H9H&rdx.ident%5Bpull%5D=omeda%7C3204I9595689H9H&oly_enc_id=3204I9595689H9H (ONC Publishes TEFCA Details, FHIR Roadmap - Healthcare Innovation) https://www.trillianthealth.com/insights/the-compass/the-data-behind-z-codes-for-social-determinants-of-health?utm_campaign=The+Compass+-+Conversions+-+Single+Image+Ads+(Media+targets)&utm_source=linkedin&utm_medium=paid&hsa_acc=506296765&hsa_cam=621026533&hsa_grp=192443563&hsa_ad=167127513&hsa_net=linkedin&hsa_ver=3&li_fat_id=e8c58a1c-d361-4617-aa45-a40cf491f4fa (The Data Behind Z Codes for Social Determinants of Health - Trilliant Health)  https://www-freethink-com.cdn.ampproject.org/c/s/www.freethink.com/entrepreneurship-innovation/robotic-suits?amp=1 (These robotic suits supercharge human workers - Free Think)

Al Dea welcomes Liz Tassey, VP of Marketing at Truveta to the show. Liz discusses how she found product marketing, her PMM superpower, essential skills needed for a career in the industry, and more.

It's about time for another news roundup from our editorial team. We look at new product launches, Microsoft Dynamics and Azure partner news, new sales figures, and some of the most popular article contributions from subject matter experts.   Show Notes: 0:45 - The launch of Microsoft Cloud for Financial Services set for Nov 1 2:00 - Report estimates Dynamics 365 Field Service closing in on $200 million in annual revenue 3:45 - Azure for healthcare: Opportunities abound in the cloud 5:00 - Microsoft to bolster Cloud for Healthcare with Truveta data platform investment & partnership 7:45 - Zuora to run subscription management services on Microsoft Azure, integrate with Dynamics 365 and Power BI 10:00 - Akerna expands ERP portfolio with $17 million acquisition of Microsoft ISV 365 Cannabis 12:15 - How Microsoft partners are building solutions with Azure Machine Learning 13:30 - Updates to Dynamics 365 media and entertainment accelerator adds Teams integration, content workflow support 14:30 - Microsoft's Power Apps Portals customers were exposing millions of private records, security firm reveals And related discussion at MSDW: Portals Community Call, September 2021: Securing Power Apps Portals Portals Community Call, August 2021: Using React with Power Apps Portals 19:15 - Features roundup How Microsoft customers should prepare for intelligent edge investment Microsoft Dynamics 365 Training Insights, Session 11: e-Commerce My favorite new features coming to Microsoft Dynamics 365 Sales, Marketing, and Customer Service in 2021 release wave 2 Power Platform 2021 Release Wave 2: Experts note developer improvements, simplified Dataverse access

Hospital-backed healthcare data company Truveta announces a deal with Microsoft. The American Medical Association's annual report finds a single insurer had at least half of the market in 46 percent of metro areas. And in response to a rise of attacks on healthcare workers, one Missouri hospital is adding panic buttons to employee badges.

This episode features Terry Myerson, CEO of Truveta. Here, he discusses his career journey, Truveta's vision of saving lives with data, truth plus knowledge, and more.

Today on Health in 2 Point 00, Jess and Matthew cover Availity raising $50 million bringing their total to $200 million and a valuation at over a billion. Revenue cycle management company Visiquate raises $50 million, bringing their total to $70 million. Truveta raises $95 million for its data analysis platform, and finally Bayesian gets $15 million using AI to predict sepsis.

In this episode of Beyond the Blue Badge, host T.A. McCann talks with his former Microsoft colleague, Terry Myerson. Terry is the CEO of Truveta, a new health tech startup that’s building a data platform to better study U.S. health using de-identified patient data. Terry was an executive vice president at Microsoft for more than 21 years before joining Madrona Venture Group and The Carlyle Group and subsequently launching Truveta. He also is part of the Seattle Sounders FC ownership group. In this episode, Terry dishes on his time at Microsoft, the opportunities that followed, utilizing his connections to soar, and how his new mission is using data to save lives.  

Terry Myerson shares about his introduction to technology, the internet, and Microsoft (2:25)  The three-dimensional filter Terry uses for evaluating and filtering data importance (5:46)Why vision is key for dealing with competition and leading a team (7:11)Terry describes how he began with Truveta and the company vision (9:07)Input on why the healthcare industry has been behind the curve with technology transformation and how Truveta will take this into account while making an impact (12:55)Privacy, ethics, and security are areas of top importance to Truveta (20:27)

Fourteen organizations including Providence Health System, Henry Ford Health System, Northwell, and others, have formed Truveta. The platform will de-identify the data and use AI to mine datasets providing new insights into the unique needs of their patient populations. In this podcast, Doug Shaw, AHA senior vice president of field engagement, speaks with Rod Hochman, president and CEO of Providence and 2021 AHA Board Chair and Terry Myerson, CEO of Truveta, about the platform and its possibilities.

Truveta is big news.  If for no other reason than it takes the poll position on data back from Epic.  But that isn't all.  It has great goals and impressive roster of participants and a massive amount of data, including mine and my families.  Toward that end I have three suggestions for the new entity.From the Press ReleaseLeading health providers have come together in unprecedented fashion to unite around the goal of improving the lives of those they serve through data insights. Health provider innovators AdventHealth, Advocate Aurora Health, Baptist Health of Northeast Florida, Bon Secours Mercy Health, CommonSpirit Health, Hawaii Pacific Health, Henry Ford Health System, Memorial Hermann Health System, Northwell Health, Novant Health, Providence health system, Sentara Healthcare, Tenet Health, and Trinity Health have formed Truveta, a new company with a vision to save lives with data.--------How can you argue with that.  I don't argue with that but I do have three ways to make it even better.    I share those on Today's Show.  What are your thoughts on this new venture?